Biomarker analysis
Biomarker Testing
With laboratory services that span the development lifecycle and industry-leading scientists with extensive drug development experience, IQVIA Laboratories can help you simplify and align co-development strategies to speed development and increase probability of regulatory and commercial success.
Our services include
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Biorepository and Specimen Management
Your biological specimens are irreplaceable assets – trust them with a proven partner
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
IQVIA Laboratories Central Laboratory Services
Central laboratory solutions supporting clinical trials around the world
Helping you master your lab data
Improved oversight with your lab data now in full view
NASH and Liver Disease Capabilities
Nonalcoholic Fatty Liver Diseases & Non-alcoholic Steatohepatitis (NAFLD & NASH)
How COVID-19 Changed Clinical Trial Dynamics and Environment
Precision Medicine World Conference 2021 Virtual Presentation
Pediatric Initiative
Optimizing small blood volumes to prevent canceled tests in clinical trials for pediatric patients
Vaccine Laboratory Services
Test Menu
SARS-CoV-2 Vaccine Induced Antibody Profiles
Presented at World Vaccine Congress 2021
Related Services
- Anatomic Pathology Laboratory Services
- Bioanalytical Services
- ADME / DMPK Services
- Biomarker Services
- Biotech Laboratory Solutions
- Central Laboratory Services
- Clinical Genomics Laboratory Services
- Companion Diagnostics (CDx)
- COVID-19 Clinical Trial Solutions
- Flow Cytometry Assay Development
- Translational Science and Innovations Laboratory Services (TSAIL)
- Vaccine Laboratory Services